IRIS
LORUSSO, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.788
EU - Europa 1.492
AS - Asia 1.272
SA - Sud America 232
AF - Africa 73
OC - Oceania 5
Totale 4.862
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.731
IT - Italia 580
SG - Singapore 515
CN - Cina 368
IE - Irlanda 190
BR - Brasile 179
DE - Germania 142
SE - Svezia 130
HK - Hong Kong 123
VN - Vietnam 85
NL - Olanda 65
AT - Austria 60
FI - Finlandia 58
GB - Regno Unito 56
RU - Federazione Russa 47
FR - Francia 45
ZA - Sudafrica 41
IN - India 37
CA - Canada 35
BD - Bangladesh 33
TR - Turchia 24
AR - Argentina 21
CZ - Repubblica Ceca 21
BE - Belgio 20
PL - Polonia 20
CI - Costa d'Avorio 18
MX - Messico 16
JP - Giappone 15
IQ - Iraq 13
KR - Corea 12
UA - Ucraina 12
EC - Ecuador 11
ES - Italia 10
IR - Iran 10
LT - Lituania 8
PK - Pakistan 8
CO - Colombia 6
RO - Romania 6
AU - Australia 5
ID - Indonesia 5
LU - Lussemburgo 5
MA - Marocco 5
VE - Venezuela 5
AZ - Azerbaigian 4
IL - Israele 4
TN - Tunisia 4
BG - Bulgaria 3
EG - Egitto 3
GR - Grecia 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
UZ - Uzbekistan 3
CH - Svizzera 2
HN - Honduras 2
MD - Moldavia 2
OM - Oman 2
PE - Perù 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GP - Guadalupe 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
RS - Serbia 1
Totale 4.862
Salva come PNG Salva come JPEG
Città #
Dallas 315
Ashburn 313
Singapore 282
Dublin 190
Parma 180
Chandler 159
Hong Kong 119
Santa Clara 99
Boardman 98
Munich 77
Beijing 65
New York 59
Ann Arbor 55
Vienna 52
Bologna 51
Los Angeles 51
Shanghai 47
Milan 44
Johannesburg 38
Ho Chi Minh City 36
Hefei 35
Dearborn 30
Helsinki 25
Moscow 22
Nanjing 22
Hanoi 21
Bremen 20
Turku 20
Amsterdam 19
Brussels 19
Verona 19
Abidjan 18
São Paulo 17
Buffalo 16
Princeton 16
Frankfurt am Main 15
Izmir 15
Reggio Emilia 15
Modena 14
Warsaw 14
Atlanta 13
Rome 13
Tokyo 13
Toronto 13
Nanchang 12
Brooklyn 11
London 11
Montreal 11
Nuremberg 11
Rio Saliceto 11
Seoul 11
Chicago 10
Columbus 10
West Jordan 10
Brno 9
Carpi 9
Chongqing 9
Olomouc 9
Redondo Beach 9
The Dalles 9
Trento 9
Denver 8
Fremont 8
Guangzhou 8
Hebei 8
Marseille 8
Pune 8
Rio de Janeiro 8
Seattle 8
Wilmington 8
Brescia 7
Houston 7
Poplar 7
Jinan 6
Lahore 6
Zhengzhou 6
Baghdad 5
Bengaluru 5
Bolzano 5
Curitiba 5
Des Moines 5
Florence 5
Guarulhos 5
Guayaquil 5
Haiphong 5
Kunming 5
Kyiv 5
Malo 5
Mexico City 5
Sector 6 5
Shenyang 5
Stockholm 5
Assago 4
Baku 4
Belo Horizonte 4
Changsha 4
Chennai 4
Düsseldorf 4
Jakarta 4
Jiaxing 4
Totale 3.168
Salva come PNG Salva come JPEG
Nome #
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 181
1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients 176
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 175
227P Sexual dimorphism in immune profile of early and advanced NSCLC 171
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 169
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 167
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 151
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 149
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 147
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 146
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 138
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 137
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 137
Assessment of Cardiac Patches Suitability for Tissue Engineering 136
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 135
Isolation and characterization of human lung lymphatic endothelial cells 135
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 130
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 130
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 126
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 121
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 118
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 116
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 116
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens 112
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 109
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 106
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 104
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 103
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 102
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 97
5P Blood immune-inflammatory dynamic unveils distinctive irAE features in ICI treated NSCLC 96
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 96
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro 95
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia 95
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 89
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 82
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 82
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 76
Deciphering the different patterns of acquired resistance in immunotherapy treated NSCLC patients through an integrated clinical and blood immuneinflammatory profiling 71
CD26 is differentially expressed throughout the life cycle of infantile hemangiomas and characterizes the proliferative phase 47
Deciphering multifaceted connections between NOTCH1 and SERCA2 proteins in the Darier's disease: a paradigmatic molecular network in the pathogenesis of a Mendelian genodermatosis 29
Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns acquired resistance to immunotherapy in patients with NSCLC 24
EHMT2/G9A drives the epigenetic regulation of glucose metabolism in T-cell Acute lymphoblastic leukemia 22
Totale 4.944
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.137
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.137
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202173 0 0 0 0 0 12 1 4 14 7 29 6
2021/202291 8 5 2 6 1 4 15 7 2 5 4 32
2022/2023767 58 70 40 71 110 72 26 45 214 7 39 15
2023/2024510 24 22 21 26 50 72 83 20 31 48 29 84
2024/20251.247 63 64 92 112 113 82 105 74 116 102 109 215
2025/20261.894 288 227 547 361 385 86 0 0 0 0 0 0
Totale 4.944